Navigation
Content
Footer
Global
Novartis site directory
Navigate Novartis
Patients & Caregivers
Healthcare Professionals
Media
Investors
Search
Our Company
Our Leadership
Board of Directors
Executive Committee of Novartis
Our Approach
Our Strategy
Our Values
Diversity & Inclusion
Our Stories
Novartis Portfolio
Global Product Portfolio
Global Clinical Pipeline
Media
All Novartis News
Media Contacts
Novartis Media Library
Stay Up-To-Date
Investors
Event Calendar
Financial Data
Share Data & Analysis
Shareholder Information
Corporate Responsibility
Corporate Responsibility at Novartis
Expanding Access to Healthcare
Ethics, Risk and Compliance
Our Business
Novartis Oncology
Novartis Pharmaceuticals
Alcon
Sandoz
Our Focus
Disease Areas
Cancer
Cardio-Metabolic
Immunology & Dermatology
Ophthalmology
Neuroscience
Respiratory
Navigate Novartis
Patients & Caregivers
Healthcare Professionals
Media
Investors
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
Our Science
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
Research & Early Development
Novartis Institutes for BioMedical Research
Research Disease Areas
Postdoc Program
Open Source Science
Drug Development at Novartis
Global Clinical Pipeline
Novartis Clinical Trials
Translational Medicine
Join Us
Your Career
Novartis Career Search
Careers in Research
Working at Novartis
Corporate Responsibility
Diversity & Inclusion
Our Values
Academic Programs
Students & Scholars
The STEP Program
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
From Our Labs
All Topics
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
From Our Labs
We push the boundaries of science in pursuit of medical breakthroughs. Here’s how.
Subscribe
Molecular glue kills cancer cells in mice
Tuning drugs to succeed on the cell’s surface
Building brain organoids to shed light on disease
With a "brain in a dish," researchers take on neurological disorders
Electrical brainstorms traced to genetic mutations
Eye disease tracked to a glitch in starburst cells
Hooked on science, Jay Bradner becomes top researcher at Novartis
When tiny brains are best for brain research
5 tips for making smart decisions on research projects
‹‹
2 of 9
››
